Cited by
Doug Walker. (2013) How Would a Ban on Prescriber-Identifying Information Impact Pharmaceutical Marketing?.
International Journal of Public and Private Healthcare Management and Economics 1:3, 38-52
Online publication date: 1-Sep-2013.
CrossRef Despina Karayanni. (2012) A Cluster Analysis of Physician’s Values, Prescribing Behaviour and Attitudes towards Firms’ Marketing Communications.
International Journal of Customer Relationship Marketing and Management 1:4, 62-79
Online publication date: 1-Oct-2012.
CrossRef Despina Karayanni. 2012. A Cluster Analysis of Physician’s Values, Prescribing Behaviour and Attitudes towards Firms’ Marketing Communications. , 250-267.
CrossRef Muhammad Zahid Iqbal,
Shahab Alam Malik,
Rashid Ahmad Khan. (2012) Answering the journalistic six on the training needs assessment of pharmaceutical sales representatives: Comparative perspectives of trainers and trainees.
International Journal of Pharmaceutical and Healthcare Marketing 6:1, 71-96
Online publication date: 1-Jan-2012.
CrossRef Hadaya Gharibyar,
Yasser Sharif. (2011) Evaluation of pharmaceutical drug information brochures in the Emirate of Abu Dhabi (United Arab Emirates).
Journal of Pharmaceutical Health Services Researchno-no
Online publication date: 1-Dec-2011.
CrossRef Xiaojing Dong,
Pradeep K. Chintagunta,
Puneet Manchanda. (2011) A new multivariate count data model to study multi-category physician prescription behavior.
Quantitative Marketing and Economics 9:3, 301-337
Online publication date: 1-Sep-2011.
CrossRef John C. Yi. (2011) Knowledge-based approach to improving detailing plan in multiple product situations using PDE weights.
Expert Systems with Applications 38:4, 3835-3843
Online publication date: 1-Apr-2011.
CrossRef Tomoaki Shimada,
Yoko Uryuhara. (2011) An Exploratory Study on the Effects of a Pharmaceutical Company's CSR Activities on Doctors' Decision Regarding Prescription Drug.
Iryo To Shakai 21:2, 189-203
Online publication date: 1-Jan-2011.
CrossRef Erin Cavusgil,
Z. Seyda Deligonul,
Roger Calantone. (2011) Late entrant over-the-counter and Rx market entry strategies: An investigation in the pharmaceutical industry.
International Journal of Pharmaceutical and Healthcare Marketing 5:2, 79-98
Online publication date: 1-Jan-2011.
CrossRef Wagner Junior Ladeira,
Marlon Dalmoro,
Alisson Eduardo Maehler,
Clécio Falcão Araujo. (2011) Drug prescription practices in Brazil: a structural equation model.
International Journal of Pharmaceutical and Healthcare Marketing 5:4, 262-278
Online publication date: 1-Jan-2011.
CrossRef Özden Gür Ali,
Murali Mantrala. (2010) Pharma rebates, pharmacy benefit managers and employer outcomes.
Health Care Management Science 13:4, 281-293
Online publication date: 1-Dec-2010.
CrossRef Sanjay Jain,
Karunesh Saxena. (2010) Lifestyle and general medicines: A study of promotional-mix strategies in India.
Journal of Medical MarketingOnline publication date: 26-Nov-2010.
CrossRef Wen-Hui Yang,
Jer-San Hu,
Ya-Yen Chou. (2010) Analysis of Network Type Exchange in the Health Care System: A Stakeholder Approach.
Journal of Medical SystemsOnline publication date: 3-Nov-2010.
CrossRef José Castro Pinto,
Alexandre Ferreira da Silva,
José Dias Curto. (2010) Determinant values in the medical act of prescribing in the Portuguese context.
Journal of Medical Marketing 10:3, 213-230
Online publication date: 1-Jul-2010.
CrossRef Peter S. H. Leeflang,
Jaap E. Wieringa. (2010) Modeling the effects of pharmaceutical marketing.
Marketing Letters 21:2, 121-133
Online publication date: 1-Jun-2010.
CrossRef Füsun F. Gönül,
Franklin J. Carter. (2010) Impact of e-detailing on the number of new prescriptions.
Health Care Management Science 13:2, 101-111
Online publication date: 1-Jun-2010.
CrossRef Ernst C. Osinga, Peter S.H. Leeflang, Jaap E. Wieringa. (2010) Early Marketing Matters: A Time-Varying Parameter Approach to Persistence Modeling.
Journal of Marketing Research 47:1, 173-185
Online publication date: 1-Feb-2010.
Abstract |
PDF (140 KB) |
PDF Plus (154 KB) Ian McCarthy. 2010. Chapter 10 A Survey on the Economics of the U.S. Pharmaceutical Industry. , 201-241.
CrossRef Michael L. Capella, Charles R. Taylor, Randall C. Campbell, Lance S. Longwell. (2009) Do Pharmaceutical Marketing Activities Raise Prices? Evidence from Five Major Therapeutic Classes.
Journal of Public Policy & Marketing 28:2, 146-161
Online publication date: 1-Nov-2009.
Abstract |
PDF (109 KB) |
PDF Plus (120 KB) SeungJin Bae,
Meredith B. Rosenthal. (2009) Pharmaceutical promotion, prior authorisation and the use of erectile dysfunction medications in the US Medicaid population.
Journal of Management & Marketing in Healthcare 2:4, 384-400
Online publication date: 1-Oct-2009.
CrossRef Nukhet Harmancioglu,
Cornelia Droge,
Roger J. Calantone. (2009) Strategic fit to resources versus NPD execution proficiencies: what are their roles in determining success?.
Journal of the Academy of Marketing Science 37:3, 266-282
Online publication date: 1-Sep-2009.
CrossRef Spencer D. Dorn,
Joel F. Farley,
Richard A. Hansen,
Nilay D. Shah,
Robert S. Sandler. (2009) Direct-to-Consumer and Physician Promotion of Tegaserod Correlated With Physician Visits, Diagnoses, and Prescriptions.
Gastroenterology 137:2, 518-524.e2
Online publication date: 1-Aug-2009.
CrossRef Stefan Stremersch, Walter Van Dyck. (2009) Marketing of the Life Sciences: A New Framework and Research Agenda for a Nascent Field.
Journal of Marketing 73:4, 4-30
Online publication date: 1-Jul-2009.
Abstract |
PDF (253 KB) |
PDF Plus (290 KB) Xiaojing Dong, Puneet Manchanda, Pradeep K. Chintagunta. (2009) Quantifying the Benefits of Individual-Level Targeting in the Presence of Firm Strategic Behavior.
Journal of Marketing Research 46:2, 207-221
Online publication date: 1-Apr-2009.
Abstract |
PDF (263 KB) |
PDF Plus (259 KB) Kissan Joseph,
Murali Mantrala. (2009) A model of the role of free drug samples in physicians’ prescription decisions.
Marketing Letters 20:1, 15-29
Online publication date: 1-Mar-2009.
CrossRef Jennifer L. Rice. (2009) Are HMO physicians more price sensitive in prescribing brand-name drugs?.
International Journal of Pharmaceutical and Healthcare Marketing 3:3, 184-209
Online publication date: 1-Jan-2009.
CrossRef Michael Stros,
Juerg Hari,
John Marriott. (2009) The relevance of marketing activities in the Swiss prescription drugs market: Two empirical qualitative studies.
International Journal of Pharmaceutical and Healthcare Marketing 3:4, 323-346
Online publication date: 1-Jan-2009.
CrossRef Gregory J. Kyle,
Lisa M. Nissen,
Susan E. Tett. (2009) The Australian rise of esomeprazole-was expenditure on samples a contributor?.
Pharmacoepidemiology and Drug Safety 18:1, 62-68
Online publication date: 1-Jan-2009.
CrossRef S KREMER,
T BIJMOLT,
P LEEFLANG,
J WIERINGA. (2008) Generalizations on the effectiveness of pharmaceutical promotional expenditures.
International Journal of Research in Marketing 25:4, 234-246
Online publication date: 1-Dec-2008.
CrossRef J GONZALEZ,
C SISMEIRO,
S DUTTA,
P STERN. (2008) Can branded drugs benefit from generic entry? The role of detailing and price in switching to non-bioequivalent molecules

.
International Journal of Research in Marketing 25:4, 247-260
Online publication date: 1-Dec-2008.
CrossRef Chen Miao-Sheng,
Shih Yu-Ti. (2008) Pricing of prescription drugs and its impact on physicians’ choice behavior.
Health Care Management Science 11:3, 288-295
Online publication date: 1-Sep-2008.
CrossRef Ramendra Singh. (2008) Network connectedness of pharmaceutical sales rep (FLE)-physician dyad and physician prescription behaviour: A conceptual model.
Journal of Medical Marketing 8:3, 257-268
Online publication date: 1-Jun-2008.
CrossRef Dileep Kumar Rohra,
Muhammad Umair Bashir,
Ummey Aymen Khwaja,
Muhammad Ressam Nazir. (2008) Critical appraisal of apparently evidence-based written advertising in Pakistan.
Pharmacy World & Science 30:3, 216-221
Online publication date: 1-Jun-2008.
CrossRef Marko Sarstedt. (2008) Market segmentation with mixture regression models: Understanding measures that guide model selection.
Journal of Targeting, Measurement and Analysis for Marketing 16:3, 228-246
Online publication date: 1-Jun-2008.
CrossRef NELS E. NELSON,
SUNG MIN KIM. (2008) A Model of Arbitral Decision Making: Facts, Weights, and Decision Elements.
Industrial Relations 47:2, 266-283
Online publication date: 1-Apr-2008.
CrossRef John C. Yi. (2008) An expert system to derive carryover effect for pharmaceutical sales detailing optimization.
Expert Systems with Applications 34:3, 1742-1753
Online publication date: 1-Apr-2008.
CrossRef G Caleb Alexander,
James Zhang,
Anirban Basu. (2008) Characteristics of Patients Receiving Pharmaceutical Samples and Association Between Sample Receipt and Out-of-Pocket Prescription Costs.
Medical Care 46:4, 394-402
Online publication date: 1-Apr-2008.
CrossRef Julie M. Donohue,
Marisa Cevasco,
Meredith B. Rosenthal. (2007) A Decade of Direct-to-Consumer Advertising of Prescription Drugs.
New England Journal of Medicine 357:7, 673-681
Online publication date: 16-Aug-2007.
CrossRef Marc Fischer,
Alexander Himme,
Sönke Albers. (2007) Pionier, Früher Folger oder Später Folger: Welche Strategie verspricht den größten Erfolg?.
Zeitschrift für Betriebswirtschaft 77:5, 539-573
Online publication date: 1-May-2007.
CrossRef Sharan Jagpal,
Kamel Jedidi,
M. Jamil. (2007) A Multibrand Concept-Testing Methodology for New Product Strategy.
Journal of Product Innovation Management 24:1, 34-51
Online publication date: 1-Jan-2007.
CrossRef Katia Campo,
Odette De Staebel,
Els Gijsbrechts,
Walter van Waterschoot. (2006) Physicians' Decision Process for Drug Prescription and the Impact of Pharmaceutical Marketing Mix Instruments.
Health Marketing Quarterly 22:4, 73-107
Online publication date: 28-Feb-2006.
CrossRef Frank Windmeijer,
Eric de Laat,
Rudy Douven,
Esther Mot. (2006) Pharmaceutical promotion and GP prescription behaviour.
Health Economics 15:1, 5-18
Online publication date: 1-Jan-2006.
CrossRef Adel I. El-Ansary. (2006) Marketing strategy: taxonomy and frameworks.
European Business Review 18:4, 266-293
Online publication date: 1-Jan-2006.
CrossRef Toshiaki Iizuka,
Ginger Zhe Jin. (2005) The Effect of Prescription Drug Advertising on Doctor Visits.
Journal of Economics <html_ent glyph="@amp;" ascii="&"/> Management Strategy 14:3, 701-727
Online publication date: 1-Sep-2005.
CrossRef K. Behan,
C. Cutts,
S. E. Tett. (2005) Motivations and perceived influences on rural and urban general practitioners when prescribing conventional non-steroidal anti-inflammatory drugs or COX-2 inhibitors.
Journal of Clinical Pharmacy and Therapeutics 30:4, 337-343
Online publication date: 1-Aug-2005.
CrossRef Natalie Mizik,
Robert Jacobson. (2004) Are Physicians ?Easy Marks?? Quantifying the Effects of Detailing and Sampling on New Prescriptions.
Management Science 50:12, 1704-1715
Online publication date: 1-Dec-2004.
CrossRef Puneet Manchanda, Peter E. Rossi, Pradeep K. Chintagunta . (2004) Response Modeling with Nonrandom Marketing-Mix Variables.
Journal of Marketing Research 41:4, 467-478
Online publication date: 1-Nov-2004.
Abstract |
References |
PDF (268 KB) |
PDF Plus (327 KB) APARNA DESHPANDE,
AJIT MENON,
MATTHEW PERRI III,
GEORGE ZINKHAN. (2004) Direct-to-Consumer Advertising and its Utility in Health Care Decision Making: A Consumer Perspective.
Journal of Health Communication 9:6, 499-513
Online publication date: 1-Nov-2004.
CrossRef Julie M. Donohue, Ernst R. Berndt . (2004) Effects of Direct-to-Consumer Advertising on Medication Choice: The Case of Antidepressants.
Journal of Public Policy & Marketing 23:2, 115-127
Online publication date: 1-Sep-2004.
Abstract |
References |
PDF (189 KB) |
PDF Plus (241 KB) M. Tolga Akcura,
Fusun F. Gonul,
Elina Petrova. (2004) Consumer Learning and Brand Valuation: An Application on Over-the-Counter Drugs.
Marketing Science 23:1, 156-169
Online publication date: 1-Jan-2004.
CrossRef K. E. M. Groves,
I. Sketris,
S. E. Tett. (2003) Prescription drug samples - does this marketing strategy counteract policies for quality use of medicines?.
Journal of Clinical Pharmacy and Therapeutics 28:4, 259-271
Online publication date: 1-Aug-2003.
CrossRef Ronald J Vogel,
Sulabha Ramachandran,
Woodie M Zachry. (2003) A 3-stage model for assessing the probable economic effects of direct-to-consumer advertising of pharmaceuticals.
Clinical Therapeutics 25:1, 309-329
Online publication date: 1-Jan-2003.
CrossRef Kirk L Wakefield,
J.Jeffrey Inman. (2003) Situational price sensitivity: the role of consumption occasion, social context and income.
Journal of Retailing 79:4, 199-212
Online publication date: 1-Jan-2003.
CrossRef John E. Calfee. (2002) The Role of Marketing in Pharmaceutical Research and Development.
PharmacoEconomics 20:Supplement 3, 77-85
Online publication date: 1-Jan-2002.
CrossRef